Home › Linfoma di Burkitt › Wisconsin › Milwaukee
Studi clinici su Linfoma di Burkitt a Milwaukee, WI
16 studi su Linfoma di Burkitt cercano partecipanti presso sedi a Milwaukee e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
In reclutamentoFase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
In reclutamentoFase 3
- Medical College of Wisconsin, Milwaukee
Blinatumomab Consolidation in Real World
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Medical College of Wisconsin, Milwaukee
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
In reclutamentoStudio osservazionale
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
In reclutamentoFase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · a 11 mi di distanza
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · a 11 mi di distanza
- e altri 1
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
In reclutamentoFase 2
- Children's Hospital of Wisconsin, Milwaukee
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
In reclutamentoFase 3
- Medical College of Wisconsin, Milwaukee
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
In reclutamentoFase 1
- Medical College of Wisconsin, Milwaukee
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
In reclutamentoFase 2
- Children's Hospital of Wisconsin, Milwaukee
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
In reclutamentoFase 3
- Children's Hospital of Wisconsin, Milwaukee
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
In reclutamentoFase 1/2
- Research Site, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
In reclutamentoFase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
In reclutamento
- Children's Wisconsin, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
In reclutamentoFase 1
- Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
In reclutamentoStudio osservazionale
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT
In reclutamentoFase 2
- Children's Hospital of Wisconsin, Milwaukee
Studi su Linfoma di Burkitt in altre città
- Houston, TX21 studi
- Philadelphia, PA16 studi
- New York City, NY14 studi
- Chicago, IL14 studi
- Cincinnati, OH12 studi
- Atlanta, GA12 studi
- Seattle, WA11 studi
- Durham, NC10 studi
- Boston, MA10 studi
- Los Angeles, CA10 studi
- Aurora, CO10 studi
- Kansas City, MO10 studi
Altri studi a Milwaukee
- Cancro al seno23 studi
- Cancro del polmone non a piccole cellule22 studi
- Cancro (tutti i tipi)22 studi
- Cancro ai polmoni21 studi
- Mieloma multiplo21 studi
- Cancro alla prostata20 studi
- Linfoma follicolare19 studi
- Cancro pancreatico18 studi
- Linfoma non Hodgkin18 studi
- Cancro ovarico17 studi
- Leucemia mieloide acuta17 studi
- Insufficienza cardiaca16 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.